Glem-Lin MXR (Empagliflozin + Linagliptin + Metformin) 10 mg/ 5 mg/ 1000 mg, 14 Ct - Nabiqasim

Glem-Lin MXR (Empagliflozin + Linagliptin + Metformin) 10 mg/ 5 mg/ 1000 mg, 14 Ct - Nabiqasim
Glem-Lin MXR from Nabiqasim represents an advanced triple-combination therapy for comprehensive Type 2 Diabetes management. Each extended-release tablet contains three proven medications: Empagliflozin 10 mg (SGLT2 inhibitor), Linagliptin 5 mg (DPP-4 inhibitor), and Metformin 1000 mg (Biguanide). This powerful formulation addresses multiple pathways of glucose control simultaneously, offering robust glycemic management in a single, convenient once-daily tablet for patients requiring intensive treatment.
- Triple-Action Therapy: Combines three complementary mechanisms for superior blood sugar control
Comprehensive Glucose Management:
- Metformin reduces liver glucose production and improves insulin sensitivity
- Linagliptin increases insulin release and decreases glucagon production
- Empagliflozin removes excess glucose through urine
- Extended-Release Formulation: The MXR version provides sustained Metformin delivery for better gastrointestinal tolerance
- Cardiovascular & Renal Benefits: Empagliflozin component offers proven cardiovascular risk reduction and kidney protection
- Convenient Regimen: Single once-daily tablet simplifies complex medication schedules
Composition
Each film coated tablet contains:
- Empagliflozin: 10 mg
- Linagliptin: 5 mg
- Metformin HCI USP (as extended release core): 1000 mg
Suggested Usage
- As directed by the physician
Legal Disclaimer
Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Glem-Lin MXR from Nabiqasim represents an advanced triple-combination therapy for comprehensive Type 2 Diabetes management. Each extended-release tablet contains three proven medications: Empagliflozin 10 mg (SGLT2 inhibitor), Linagliptin 5 mg (DPP-4 inhibitor), and Metformin 1000 mg (Biguanide). This powerful formulation addresses multiple pathways of glucose control simultaneously, offering robust glycemic management in a single, convenient once-daily tablet for patients requiring intensive treatment.
- Triple-Action Therapy: Combines three complementary mechanisms for superior blood sugar control
Comprehensive Glucose Management:
- Metformin reduces liver glucose production and improves insulin sensitivity
- Linagliptin increases insulin release and decreases glucagon production
- Empagliflozin removes excess glucose through urine
- Extended-Release Formulation: The MXR version provides sustained Metformin delivery for better gastrointestinal tolerance
- Cardiovascular & Renal Benefits: Empagliflozin component offers proven cardiovascular risk reduction and kidney protection
- Convenient Regimen: Single once-daily tablet simplifies complex medication schedules
Composition
Each film coated tablet contains:
- Empagliflozin: 10 mg
- Linagliptin: 5 mg
- Metformin HCI USP (as extended release core): 1000 mg
Suggested Usage
- As directed by the physician
Legal Disclaimer
Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.











